Brief Reports
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. May 14, 2005; 11(18): 2822-2826
Published online May 14, 2005. doi: 10.3748/wjg.v11.i18.2822
Table 6 Comparison of the density of proliferation and apoptosis with severe dysplasia in the model-agent group, sulindac-preventative group and sulindac-curative group (number/mm2).
GroupnProliferative cell density (mean±SD)Apoptotic cell density (mean±SD)Ratio (apoptosis/proliferation)
Model8159.0±45.961.0±24.60.38
Preventive3155.8±31.988.5±14.60.57
Curative5159.8±22.764.2±19.10.4